MCM
IONS icon

Montibus Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Montibus Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-392,962
Closed -$10.6M – 130
2013
Q2 		$10.6M Buy
+392,962
New +$8.36M 1.34% 35

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Montibus Capital Management's IONS Position: Q3 2013 in Review

Montibus Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2013, closing a stake of 392,962 shares — an estimated $10.6M sold.

Montibus Capital Management first reported a position in IONS in Q2 2013 and held it in 1 quarter. The position peaked at $10.6M in Q2 2013. 204 funds tracked by Wall St. Rank hold IONS as of Q3 2013.

  • Montibus Capital Management reported no remaining Ionis Pharmaceuticals position as of Q3 2013 after selling out during the quarter.
  • Montibus Capital Management sold 392,962 Ionis Pharmaceuticals shares in Q3 2013, an estimated $10.6M.
  • Montibus Capital Management first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 1 quarter.
  • Montibus Capital Management's Ionis Pharmaceuticals position peaked at $10.6M in Q2 2013.
  • 204 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2013.

Based on Montibus Capital Management's 13F filing for Q3 2013, filed 13 Nov 2013.